Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abciximab to reduce coronary microembolism during PCI in stable angina
DRKS00000603Phase 4Not yet recruiting
- Sponsor
- Universitätsklinikum Jena
- Start
- Nov 2010
- Modality
- Antibody Fragments → Engineered Antibody Formats → Antibody-Based Therapeutics, Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Chronic Coronary Syndrome (CCS) comparing Abciximab arm with Placebo arm (2 arms). Planned start Nov 2010; status: not yet recruiting.
02
Drugs
abciximab
03
Conditions
Chronic Coronary Syndrome (CCS)
Beyond the preview
Go deeper on DRKS00000603.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00000603.